Progress in Vaccination against Haemophilus influenzae type b in the Americas
Open Access
- 22 April 2008
- journal article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 5 (4), e87
- https://doi.org/10.1371/journal.pmed.0050087
Abstract
The authors review the progress to date in Hib vaccine introduction, the lessons learned, and the remaining challenges.Keywords
This publication has 39 references indexed in Scilit:
- Introducción de la vacuna conjugada contra Hib en Chile y UruguayRevista Panamericana de Salud Pública, 1999
- Haemophilus influenzae type b disease and vaccination in Latin America and the CaribbeanThe Pediatric Infectious Disease Journal, 1997
- Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infantsThe Lancet, 1997
- Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infectionsThe Pediatric Infectious Disease Journal, 1996
- Cost Benefit of Combining AntigensBiologicals, 1994
- Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group.1993
- Cost-Benefit Analysis for the Use of Haemophilus influenzae Type b Conjugate Vaccine in Santiago, ChileAmerican Journal of Epidemiology, 1993
- Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccineThe Journal of Pediatrics, 1993
- Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford regionThe Lancet, 1992
- Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in InfancyNew England Journal of Medicine, 1987